Skip to content

Innoviva, Inc. INVA Other income, net (Note 6)

Other income, net (Note 6) at other companies

Savara logo
SavaraSVRA
$1.71M-5.0%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
-$1.18M+53.0%
Pfizer logo
PfizerPFE
Merck & Co. logo
Merck & Co.MRK
AbbVie logo
AbbVieABBV
Insmed logo
InsmedINSM

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.41B+9.7%
P/E3.5×
P/S4.2×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s other income, net (note 6)?
Innoviva, Inc. (INVA) reported other income, net (note 6) of -$366K in Q1 2026.
How has Innoviva, Inc.'s other income, net (note 6) changed year-over-year?
Innoviva, Inc.'s other income, net (note 6) increased by 63.3% year-over-year, from -$996K to -$366K.
What is the long-term trend for Innoviva, Inc.'s other income, net (note 6)?
Over 4 years (2021 to 2025), Innoviva, Inc.'s other income, net (note 6) has grown at a -5.7% compound annual growth rate (CAGR), from -$3.63M to -$2.86M.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.